AptaBio Therapeutics Inc. (293780.KQ) KOE

8,330.00

-120(-1.42%)

Updated at December 05 10:41AM

Currency In KRW

Valuation

Market Cap146.92B
Enterprise Value128.9B
P/E Ratio-9.02
PEG Ratio-0.75
Price/Sales Ratio73.07
Price/Book Ratio4.78
Enterprise/Revenue68.87
Enterprise/EBITDA-13.86

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-8.1
Operating Margin-6.2

Management Effectiveness

Return On Assets-0.36
Return On Equity-0.5

Income Statement

Revenue3.36B
Revenue/Share115.64
Gross Profit286.62M
EBITDA-23.87B
Net Income-29.38B
Diluted EPS-1,273.72

Balance Sheet

Total Cash22.57B
Total Cash/Share839.67
Total Debt8.5B
Total Debt/Equity0.18
Current Ratio1.46
Book Value Per Share1,767.09

Price History

52-Week Change28.22
52-Week High11,960
52-Week Low5,750
Moving Average 50 Days7,727.8
Moving Average 200 Days7,852.55

Statistics

Average Volume174,825
Shares Outstanding26.88M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor2:1
Last Split DateAugust 24, 2021